[Federal Register Volume 87, Number 88 (Friday, May 6, 2022)]
[Notices]
[Pages 27173-27174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-09776]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Statement of Delegation of Authority

    Notice is hereby given that I have delegated to the Director, 
National Institutes of Health (NIH), the authorities vested in the 
Secretary of Health and Human Services under Section 2 of the 
Accelerating Access to Critical Therapies for ALS Act (Pub. L. 117-79), 
as amended, to award grants to participating entities for purposes of 
scientific research utilizing data from expanded access to 
investigational drugs for individuals who are not otherwise eligible 
for clinical trials for the prevention, diagnosis, mitigation, 
treatment, or cure of amyotrophic lateral sclerosis.
    These authorities may be redelegated. Exercise of this authority 
shall be in accordance with established policies, procedures, 
guidelines, and regulations as prescribed by the Secretary. The 
Secretary retains the authority to submit reports to Congress and 
promulgate regulations.
    This delegation is effective immediately. I hereby affirm and 
ratify any actions taken by you or your subordinates that involved the 
exercise

[[Page 27174]]

of the authorities delegated herein prior to the effective date of the 
delegation.

Xavier Becerra,
Secretary.
[FR Doc. 2022-09776 Filed 5-5-22; 8:45 am]
BILLING CODE 4140-01-P